C07F 9/08
Esters of oxyacids of phosphorus
Official title: Esters of oxyacids of phosphorus {(C07F9/062 takes precedence)}
C07F9/08 (Esters of oxyacids of phosphorus) appears on 3,188 US grants and 2,296 published applications in this corpus.
Search patents in C07F- Granted patents
- 3,188
- Published applications
- 2,296
- Assignees
- 1,446
- Inventors
- 6,607
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 89 | 0 |
| 1977 | 59 | 0 |
| 1978 | 78 | 0 |
| 1979 | 49 | 0 |
| 1980 | 52 | 0 |
| 1981 | 60 | 0 |
| 1982 | 43 | 0 |
| 1983 | 33 | 0 |
| 1984 | 32 | 0 |
| 1985 | 63 | 0 |
| 1986 | 36 | 0 |
| 1987 | 55 | 0 |
| 1988 | 50 | 0 |
| 1989 | 56 | 0 |
| 1990 | 42 | 0 |
| 1991 | 53 | 0 |
| 1992 | 71 | 0 |
| 1993 | 70 | 0 |
| 1994 | 50 | 0 |
| 1995 | 54 | 0 |
| 1996 | 58 | 0 |
| 1997 | 70 | 0 |
| 1998 | 102 | 0 |
| 1999 | 75 | 0 |
| 2000 | 59 | 0 |
| 2001 | 71 | 14 |
| 2002 | 78 | 67 |
| 2003 | 71 | 70 |
| 2004 | 55 | 97 |
| 2005 | 31 | 94 |
| 2006 | 47 | 102 |
| 2007 | 54 | 77 |
| 2008 | 53 | 80 |
| 2009 | 52 | 72 |
| 2010 | 69 | 109 |
| 2011 | 72 | 94 |
| 2012 | 81 | 100 |
| 2013 | 68 | 91 |
| 2014 | 82 | 109 |
| 2015 | 82 | 100 |
| 2016 | 74 | 98 |
| 2017 | 74 | 109 |
| 2018 | 96 | 122 |
| 2019 | 84 | 110 |
| 2020 | 92 | 96 |
| 2021 | 75 | 86 |
| 2022 | 59 | 87 |
| 2023 | 61 | 88 |
| 2024 | 54 | 81 |
| 2025 | 64 | 77 |
| 2026 | 30 | 66 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Biosynthesis of chemically diversified non-natural terpene products6 Oct 2026US 12,753,423 B2Board of Trustees of Michigan State University
- Organic compound, perovskite precursor solution, perovskite film, perovskite cell, and electric apparatus29 Sep 2026US 12,751,201 B2Contemporary Amperex Technology Co., Limited
- Process for preparing a phosphoramidite and further reaction thereof to the monophosphite22 Sep 2026US 12,741,979 B2Evonik Oxeno GmbH
- Probe directed to enzyme ALDH1A3 and use thereof in the diagnosis of glioblastoma15 Sep 2026US 12,734,254 B2Universita Degli Studi Del Piemonte Orientale “A. Avogadro”
- Nutritional compositions containing phosphatidylserine powder18 Aug 2026US 12,708,636 B2Frutarom Limited
- Long-Lived Gadolinium Based Tumor Targeted Imaging and Therapy Agents8 Oct 2026US 2026/0306634 A1Wisconsin Alumni Research Foundation
- Hydrocarbon terminal group-containing compound, surface treatment agent, and article8 Oct 2026US 2026/0308392 A1Shin-Etsu Chemical Co., Ltd.
- Lipids and nanoparticle formulations thereof1 Oct 2026US 2026/0295080 A1Arcturus Therapeutics, Inc.
- Additives for Thermal Management Fluid and Thermal Management Fluid Compositions Including Same1 Oct 2026US 2026/0297410 A1SK Innovation Co., Ltd.
- Novel phosphate compounds and process for preparation thereof17 Sep 2026US 2026/0272959 A1
Most cited
By later US patents
- Synthetic phosphatidyl cholines useful in forming liposomes664US 4,485,045 AResearch Corporation · 1984
- Oligonucleotides with selectably cleavable and/or abasic sites574US 5,367,066 AChiron Corporation · 1994
- Lipopolyamines, their preparation and their use287US 5,171,678 ACentre National De La Recherche Scientifique · 1992
- Phosphoramidate and phosphorothioamidate oligomeric compounds271US 5,637,684 AIsis Pharmaceuticals, Inc. · 1997
- Cationic lipids and the use thereof249US 5,830,430 AImaRx Pharmaceutical Corp. · 1998